Waters Corporation

WAT Healthcare Diagnostics & Research

Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024. In the quarter to June 2026, revenue grew 113.4%, EPS fell 156.3%, free cash flow grew 750.0% and total debt rose 308.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

436.95 7.20 −1.62%
Market cap
$43.6B
P/E
109×
Fwd P/E
44.3×
Dividend yield
—
F-score
5/9
Altman Z
9.63
Beneish M
−2.37
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
1.92% 5.21% 29.27% 32.96%

+8 more TTM periods

Piotroski F-Score
4 2 5 6
ROA
1.13% 3.09% 13.35% 13.83%
ROIC
1.05% 1.92% 17.17% 18.28%
Return on Tangible Assets
4.69% 13.58% 41.43% 49.69%
Average Days of Receivables
156.16 169.71 95.59 87.97
Free Cash Flow per Share
3.73 2.82 8.53 10.12
Free Cash Flow
366.60 231.60 507.60 602.27
Other line items

Show all line items

Columns are period end dates